Werfen is a global leader in in vitro diagnostics (IVD) in the specialties of Hemostasis, Critical Care and Autoimmunity. Our core business is dedicated to R&D, manufacturing and distribution of diagnostic systems for hospitals and clinical laboratories. Our other areas of expertise include Original Equipment Manufacturing, IVD & Clinical Software, Clinical Chemistry, Infusion Therapy, and Medical Devices Distribution.

We operate directly in over 30 countries and in more than 100 territories through distributors. In 2016, our turnover was approximately 1.2 billion euros and we had an average workforce of 4,400 people.